Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced vancomycin susceptibility in Staphylococcus aureus clinical isolates: a spectrum of less investigated uncertainties

29 Oct 2024

Abstract excerpt

BACKGROUND: Staphylococcus aureus clinical isolates with vancomycin MICs of 2 µg/ml have been associated with vancomycin therapeutic failure and the heterogenous vancomycin-intermediate S. aureus (hVISA) phenotype. While carriage of van genes has usually been associated with higher level of MIC and frank vancomycin resistance, the unrecognized risk of hetero-resistance is frequently underestimated. Methods used...

Topics

Join the communities discussing this publication.

Antimicrobial Resistance in Staphylococcus
Bacterial biofilms and quorum sensing
Clostridium difficile and Clostridium perfringens research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 39472820
DOI: 10.1186/s12879-024-10047-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced vancomycin susceptibility in Staphylococcus aureus clinical isolates: a spectrum of less investigated uncertaintiesPMID 39472820Read ↗

Acquired Vancomycin Resistance in Clinically Relevant PathogensSemantic proximity Read ↗

VanA-Positive Vancomycin–Resistant Staphylococcus aureusSemantic proximity Read ↗

Reduced Vancomycin Susceptibility Found in Methicillin-Resistant and Methicillin-Sensitive Staphylococcus aureus Clinical Isolates in Northeast ChinaSemantic proximity Read ↗

Molecular characterization of vancomycin-resistant Staphylococcus aureus strains isolated from clinical samples: A three year study in Tehran, IranSemantic proximity Read ↗

Reduced Vancomycin Susceptibility in <i>Staphylococcus aureus</i> , Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical ImplicationsSemantic proximity Read ↗

Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United StatesSemantic proximity Read ↗

Phenotypic and molecular identification of vancomycin resistance in clinical Staphylococcus aureus isolates in Osogbo, NigeriaSemantic proximity Read ↗

Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.Semantic proximity Read ↗

Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin AmericaSemantic proximity Read ↗

Phenotypic and Molecular Characterization of Vancomycin and Linezolid Resistance in Clinical Isolates of Staphylococcus aureusSemantic proximity Read ↗

Vancomycin-resistant staphylococci and enterococci: epidemiology and controlSemantic proximity Read ↗

Vancomycin Resistance in Enterococcus and Staphylococcus aureusSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.